NONMEM Users Network Archive

Hosted by Cognigen

Pharmacometrics Team Leader Position at Boehringer Ingelheim

Date: Mon, 28 Aug 2017 21:19:34 +0000

Are your looking for your next career step as a Team Leader Pharmacometrics=
 at Boehringer Ingelheim? If yes, you will convince us if you...
... apply a question-based fit-for-purpose approach to inform all phases of=
 drug development using state-of-the-art PMx approaches
...are able to provide strategic leadership to develop and maintain a highl=
y competitive and regulatory compliant PMx team.

In case you identify yourself with all these challenges, take the chance an=
d apply now!

Tasks & Responsibilities

As a team leader within Global Pharmacometrics (PMx), you ensure not only t=
he development and implementation of model-informed drug discovery and deve=
lopment (MID3) strategies for clinical drug development projects. You will =
also be responsible for an appropriate planning, execution, and reporting o=
f a wide variety of pharmacometric analyses on a clinical trial and project=
 level by your team. The development and implementation of innovative pharm=
acometrics approaches for supporting decision ma-king in clinical drug deve=
lopment and regulatory approval will also be your key responsibility

You lead employees efficiently from the onboarding process, to the regular =
performance assessment with constructive feedback and fostering further dev=

You set directions and standards while supervise processes: After careful o=
bservation, you will launch and implement changes to improve procedures con=

You will contribute to and maintain an open atmosphere within our attractiv=
e working environment. That means you will set an example for a performance=
-based team culture with clear accountabilities and a sense of urgency for =
achieving results. As member of the PMx leadership team, you significantly =
contribute to the development and implementation of global PMx goals and st=

In your leadership function, you will represent global PMx at relevant inte=
rnal and external meetings and promote PMx and MID3.

On top, you will act as a Project Pharmacometrician. Therefore, you will de=
velop our PMx strategy, perform the respective analyses and represent PMx a=
s author of reports and other regulatory relevant documents in project team=
s and regulatory meetings.


Master's Degree from an accredited institution in Medicine or Pharma-cometr=
ics, Clinical Pharmacology, Pharmacy, Mathematics, Biology, Statistics or e=
quivalent area of focus with a minimum of 7 years of experience in Pharmaco=
metrics in the pharmaceutical industry, regulatory agencies, or academia or

MD/PhD in from an accredited institution in Medicine, Clinical Pharmacology=
, Pharmacy, Mathematics, Biology, Statistics or relevant area of focus with=
 a minimum of 5 years of experience in Pharmacometrics in the pharmaceutica=
l industry, regulatory agencies, or academia

Successful track record of managing and developing direct reports

Experienced in applying PMx software, e.g., NONMEM, Monolix, R, SAS, PKSim,=
 MATLAB or SimBiology

Proficient knowledge in clinical pharmacology, clinical drug development, M=
ID3, and regulatory guidelines

Excellent communication skills and willingness to continuous personnel and =
subject-specific development

Enthusiastic personality, with the constructive willingness to succeed with=
 the team

Benjamin Weber, PhD
Director, Pharmacometrics
Translational Medicine & Clinical Pharmacology
Boehringer Ingelheim Pharmaceuticals, Inc.
Ridgefield, Connecticut
P: 203-791-6240

CONFIDENTIALITY NOTICE: This e-mail message, including any attachments, is =
for the sole use of the intended recipient(s) and may contain confidential =
and privileged information. Any unauthorized review, use, disclosure of dis=
tribution is prohibited. If you are not the intended recipient, please con=
tact sender by reply e-mail and destroy all copies of the original message.

Received on Mon Aug 28 2017 - 17:19:34 EDT

The NONMEM Users Network is maintained by ICON plc. Requests to subscribe to the network should be sent to:

Once subscribed, you may contribute to the discussion by emailing: